"Optimizing Diabetes Control with DAPA VILDA 50/5"

Mar 13, 2024

DAPA VILDA 50/5

Dapagliflozin (5mg), Vildagliptin SR (50mg)

Dapagliflozin (5mg)

Introduction to Dapavilda Dapavilda is a novel oral diabetes medication that helps control blood sugar levels. It belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. By blocking the SGLT2 protein in the kidneys, dapagliflozin prevents glucose from being reabsorbed into the blood, promoting its excretion through urine.

Benefits of Dapagliflozin

  • Enhances blood sugar control in adults with type 2 diabetes
  • Aids in weight loss when used as part of a diabetes management plan
  • Shows potential in reducing the risk of hospitalization for heart failure in patients with type 2 diabetes and existing cardiovascular disease

Side Effects and Considerations

  • Risk of urinary tract infections due to increased sugar in urine
  • Possible dehydration and low blood pressure
  • Not recommended for patients with severe kidney impairment

Vildagliptin SR (50mg)

Introduction to Vildagliptin Vildagliptin is a member of the dipeptidyl peptidase-4 (DPP-4) inhibitors class of drugs. It works by increasing the levels of incretin hormones in the body, which in turn boosts the production of insulin when blood sugar levels are high. Additionally, it helps to decrease the amount of sugar made by the liver.

Benefits of Vildagliptin

  • Improves blood sugar control in type 2 diabetes patients
  • Less risk of causing hypoglycemia (abnormally low blood sugar levels) compared to other diabetes medications
  • Does not significantly affect body weight

Side Effects and Considerations

  • Potential risk of developing pancreatitis
  • May cause joint pain and skin reactions
  • Should be used with caution in patients with liver disease

DAPA VILDA 50/5

Combination Therapy: Synergistic Effects The combination of Dapagliflozin (5mg) and Vildagliptin SR (50mg) offers a synergistic approach to managing type 2 diabetes. This dual therapy leverages the benefits of both medications, providing a more comprehensive control over blood sugar levels.

Key Advantages

  • Enhanced glycemic control without the significant risk of hypoglycemia
  • Potential for additional cardiovascular benefits
  • May offer convenience with fewer pills required

Considerations for Patients

  • Patients should monitor for signs of dehydration and urinary tract infections
  • Regular monitoring of kidney function is advised
  • The combination therapy should be part of a broader diabetes management plan that includes diet and exercise

Conclusion The combined use of Dapagliflozin and Vildagliptin represents a modern approach to managing type 2 diabetes, offering benefits in blood sugar control, potential cardiovascular advantages, and convenience for the patient. As with any medication, it's important to consider the individual's overall health, potential side effects, and the advice of a healthcare professional.  A group of highly skilled pharmaceutical professionals founded a specialist pharmaceutical in February 2018 such as Steris Healthcare Pvt Ltd.Sterispharma is a WHO, GMP, and ISO-certified pharma company based in Navi Mumbai. They provide quality medicines at the best price to customers in India as per the standard parameters of WHO. With a steris online pharmacy, you can buy and get home delivery of medicines at your doorsteps. Our main goal at Steris is to provide a wide range of healthcare goods to meet the various needs of the healthcare sector. Steris is dedicated to satisfying the needs of the healthcare industry, whether it be with regard to specialty treatments, rare disease meds, or necessary pharmaceuticals. Steris healthcare products range covers almost every cadre of requirement in today's Medical scenario, widely prescribed under categories like Cardiology, Asthama, Respiratory, Nasal, Diabetic, Endocrinology, Cadiology, Gastrology, Orthopaedic, Anti-infective/antibiotic, General, Urology, Neurology, Nephrology, Oncology, Gynaecology, Pediatric, Dental & Derma range of Products.

For further more information:

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com    

CALL:: 7877551268, 8209542042, 8955945010, 6377716668   

WHATSAPP:: MONA, HARSHITA, SAKSHI, SHWETA   

BUY NOW   

 

 

 

 

 

SHARE WITH